Sign in

Trial result ·

White matter hyperintensities moderate neuropsychiatric response to N-acetylcysteine and exercise therapy in vascular mild cognitive impairment.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This trial included people with vascular mild cognitive impairment. People were put by chance into a drug group or a dummy pill group. The drug was N-acetylcysteine, 2400 mg each day. Both groups also did exercise for 6 months. Brain scans measured the amount of white matter hyperintensities. Mood and behavior symptoms were checked at the start, 3 months and 6 months.

What they found

The team looked at how the scans related to symptom change. In the drug plus exercise group, a pattern appeared. People with fewer hyperintensities at the start had larger drops in symptoms. This held for the front part of the brain. It also held for the brain as a whole. These gains came mainly from less apathy over 6 months.

What it means for patients

The authors say the amount of these brain changes shapes treatment response. Symptoms may ease more in people with fewer of these changes. The authors also stress care for blood vessel risk factors. They describe people with this condition as a vulnerable group.

Why it is not certain yet

The abstract does not say how many people were in each group. Follow-up lasted 6 months, so longer effects are not known. The abstract does not say whether the drug beat the dummy pill overall. It also does not report side effects. Links found in this kind of analysis may not prove cause.

Source

White matter hyperintensities moderate neuropsychiatric response to N-acetylcysteine and exercise therapy in vascular mild cognitive impairment.

PubMed · PMID 42842469

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Mild cognitive impairment publications